Clinical Trials Browser

Not yet recruiting × Carcinoma, Non-Small-Cell Lung × Surgical Procedures, Operative × Clear all

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07432802 2026-02-27

STRADOS

Phase NA Not yet recruiting

182 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07177092 2025-09-16

SURGAN-TKI

Phase 2 Not yet recruiting

118 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06998719 2025-05-31

ACCESS

Phase 2 Not yet recruiting

80 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06743555 2024-12-20

SAVED LUNG

Phase 1 Not yet recruiting

14 enrolled

Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT06591910 2024-09-19

Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Not yet recruiting

50 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06394427 2024-05-01

Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

Not yet recruiting

250 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06282536 2024-02-28

Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Trial

Phase 2 Not yet recruiting

20 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05891080 2023-06-06

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

Phase 2 Not yet recruiting

124 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04465968 2020-07-10

DEEP_OCEAN

Phase 3 Not yet recruiting

84 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Pancoast Syndrome

Clinical Trials

GIVEN

STRADOS

SURGAN-TKI

ACCESS

SAVED LUNG

Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

Neoadjuvant Therapy With Iruplinalkib for Potentially Resectable ALK Positive NSCLC: A Single Arm, Exploratory Trial

Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

DEEP_OCEAN